149 related articles for article (PubMed ID: 37232001)
1. A Comparison of Clinical Outcomes for Subependymal Giant Cell Astrocytomas Treated with Laser Interstitial Thermal Therapy, Open Surgical Resection, and mTOR Inhibitors.
Boop S; Bonda D; Randle S; Leary S; Vitanza N; Crotty E; Novotny E; Friedman S; Ellenbogen RG; Durfy S; Goldstein H; Ojemann JG; Hauptman JS
Pediatr Neurosurg; 2023; 58(3):150-159. PubMed ID: 37232001
[TBL] [Abstract][Full Text] [Related]
2. Laser interstitial thermal therapy compared with open resection for treating subependymal giant cell astrocytoma.
Aum DJ; Reynolds RA; McEvoy SD; Wong M; Roland JL; Smyth MD
J Neurosurg Pediatr; 2024 Jan; 33(1):95-104. PubMed ID: 37922551
[TBL] [Abstract][Full Text] [Related]
3. Laser interstitial thermal therapy for subependymal giant cell astrocytoma: technical case report.
Dadey DY; Kamath AA; Leuthardt EC; Smyth MD
Neurosurg Focus; 2016 Oct; 41(4):E9. PubMed ID: 27690646
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic laser ablation for subependymal giant cell astrocytomas: personal experience and review of the literature.
Desai VR; Jenson AV; Hoverson E; Desai RM; Boghani Z; Lee MR
Childs Nerv Syst; 2020 Nov; 36(11):2685-2691. PubMed ID: 32468241
[TBL] [Abstract][Full Text] [Related]
5. Current trends in the management of subependymal giant cell astrocytomas in tuberous sclerosis.
Frassanito P; Noya C; Tamburrini G
Childs Nerv Syst; 2020 Oct; 36(10):2527-2536. PubMed ID: 32978642
[TBL] [Abstract][Full Text] [Related]
6. Subependymal giant-cell astrocytoma: A surgical review in the modern era of mTOR inhibitors.
Danassegarane G; Tinois J; Sahler Y; Aouaissia S; Riffaud L
Neurochirurgie; 2022 Dec; 68(6):627-636. PubMed ID: 35907444
[TBL] [Abstract][Full Text] [Related]
7. Neurosurgical treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex: a series of 44 surgical procedures in 31 patients.
Giordano F; Moscheo C; Lenge M; Biagiotti R; Mari F; Sardi I; Buccoliero AM; Mongardi L; Aronica E; Guerrini R; Genitori L
Childs Nerv Syst; 2020 May; 36(5):951-960. PubMed ID: 31853898
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological treatment strategies for subependymal giant cell astrocytoma (SEGA).
Ebrahimi-Fakhari D; Franz DN
Expert Opin Pharmacother; 2020 Aug; 21(11):1329-1336. PubMed ID: 32338549
[TBL] [Abstract][Full Text] [Related]
9. Recent management trends of subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
Shah Z; Tameezuddin A; Saeed Baqai MW; Shami MS
J Pak Med Assoc; 2023 Feb; 73(2):430-432. PubMed ID: 36800747
[TBL] [Abstract][Full Text] [Related]
10. Dose-level response rates of mTor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
Weidman DR; Pole JD; Bouffet E; Taylor MD; Bartels U
Pediatr Blood Cancer; 2015 Oct; 62(10):1754-60. PubMed ID: 25929843
[TBL] [Abstract][Full Text] [Related]
11. A management strategy for intraventricular subependymal giant cell astrocytomas in tuberous sclerosis complex.
Harter DH; Bassani L; Rodgers SD; Roth J; Devinsky O; Carlson C; Wisoff JH; Weiner HL
J Neurosurg Pediatr; 2014 Jan; 13(1):21-8. PubMed ID: 24180681
[TBL] [Abstract][Full Text] [Related]
12. Acute Management of Symptomatic Subependymal Giant Cell Astrocytoma With Everolimus.
Arroyo MS; Krueger DA; Broomall E; Stevenson CB; Franz DN
Pediatr Neurol; 2017 Jul; 72():81-85. PubMed ID: 28511812
[TBL] [Abstract][Full Text] [Related]
13. Isolated subependymal giant cell astrocytoma (SEGA) in the absence of clinical tuberous sclerosis: two case reports and literature review.
Cobourn KD; Chesney KM; Mueller K; Fayed I; Tsering D; Keating RF
Childs Nerv Syst; 2024 Jan; 40(1):73-78. PubMed ID: 37658938
[TBL] [Abstract][Full Text] [Related]
14. [Subependymal Giant Cell Astrocytoma with Tuberous Sclerosis Complex(TSC-SEGA)].
Ichikawa T; Niida Y
No Shinkei Geka; 2022 Jan; 50(1):111-121. PubMed ID: 35169091
[TBL] [Abstract][Full Text] [Related]
15. Trapped ventricle after laser ablation of a subependymal giant cell astrocytoma complicated by intraventricular gadolinium extravasation: case report.
Karsy M; Patel DM; Bollo RJ
J Neurosurg Pediatr; 2018 May; 21(5):523-527. PubMed ID: 29451453
[TBL] [Abstract][Full Text] [Related]
16. Presurgical Administration of mTOR Inhibitors in Patients with Large Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis Complex.
Jiang T; Du J; Raynald ; Wang J; Li C
World Neurosurg; 2017 Nov; 107():1053.e1-1053.e6. PubMed ID: 28866062
[TBL] [Abstract][Full Text] [Related]
17. Advances in the management of subependymal giant cell astrocytoma.
Beaumont TL; Limbrick DD; Smyth MD
Childs Nerv Syst; 2012 Jul; 28(7):963-8. PubMed ID: 22562196
[TBL] [Abstract][Full Text] [Related]
18. Subependymal giant cell astrocytoma: current concepts, management, and future directions.
Ouyang T; Zhang N; Benjamin T; Wang L; Jiao J; Zhao Y; Chen J
Childs Nerv Syst; 2014 Apr; 30(4):561-70. PubMed ID: 24549759
[TBL] [Abstract][Full Text] [Related]
19. The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
Weidman DR; Palasamudram S; Zak M; Whitney R; McCoy B; Bouffet E; Taylor M; Shroff M; Bartels U
J Neurooncol; 2020 May; 147(3):731-736. PubMed ID: 32285309
[TBL] [Abstract][Full Text] [Related]
20. Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex-Current Views on Their Pathogenesis and Management.
Gao C; Zabielska B; Jiao F; Mei D; Wang X; Kotulska K; Jozwiak S
J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
